TITLE

Earnings Roundup

PUB. DATE
October 2007
SOURCE
BioWorld Today;10/22/2007, Vol. 18 Issue 205, p4
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on Angiotech Pharmaceuticals Inc.'s third-quarter 2007 earnings. The Vancouver, British Columbia-based company announced total revenues of $68 million, down from $86 million in the same period in 2006, and said it expected to post a net loss. Angiotech's shares also fell and closed at $4.98.
ACCESSION #
27171378

 

Related Articles

  • Financing Roundup.  // BioWorld Today;7/27/2009, Vol. 20 Issue 142, p3 

    This section offers news briefs related to the financial deals in the biotechnology industry. A shelf prospectus was filed by Angiotech Pharmaceuticals Inc. to raise up to 250 million U.S. dollars during the next 25 months. OncoGenex Pharmaceuticals Inc. finished its registered direct offering...

  • Financings roundup.  // Medical Device Daily;8/25/2008, Vol. 12 Issue 183, p3 

    The article reports that Angiotech Pharmaceuticals has extended the date on which the offer will expire for the previously announced tender offer for its outstanding senior floating rate notes due 2013, and its outstanding 7.75% senior subordinated notes due 2014. It was mentioned that the...

  • FINANCINGS ROUNDUP.  // BioWorld Today;6/4/2009, Vol. 20 Issue 106, p4 

    This section offers news briefs related to the financial status of pharmaceutical companies. Biovail Corp. announced that it will provide up to $200 million aggregate principal amount of its senior convertible notes in a private offering to qualified institutional buyers. Thallion...

  • Thermo Fisher to buy shares; Angiotech extends deadline.  // Medical Device Daily;9/15/2008, Vol. 12 Issue 197, p4 

    The article reports on a stock repurchase authorized by the board of directors of Thermo Fisher Scientific. The company will repurchase $500 million shares of its own common stock in the open market or in negotiated transactions through September 10, 2009. Thermo Fisher serves its customers...

  • Financings roundup.  // Medical Device Daily;9/15/2008, Vol. 12 Issue 197, p4 

    The article reports that Angiotech Pharmaceuticals , a specialty pharmaceutical and medical device company has extended the expiration date of its tender offer for its outstanding senior floating rate notes due 2013, and its outstanding 7.75 percent senior subordinated notes due 2014. According...

  • Financings roundup.  // Medical Device Daily;5/5/2009, Vol. 13 Issue 85, p3 

    The article offers updates on financing in the medical device industry. Pulse Systems has reported that it has closed an $8.5 million credit facility through the Structured Finance Group at Fifth Third Bank. Specialty bio-therapeutics company Haemacure has entered into a term sheet with...

  • OTHER NEWS TO NOTE.  // BioWorld Today;4/8/2010, Vol. 21 Issue 67, p2 

    This section offers news briefs concerning the biotechnology industries. An agreement for additional nondilutive financing has been approved by both Ambrilia Biopharma Inc. and its subsidiary, Cellpep Pharma Inc. A contract to provide genetically modified animals was renewed by GenOway SA. All...

  • FINANCINGS ROUNDUP.  // BioWorld Today;7/9/2008, Vol. 19 Issue 132, p8 

    This section offers news briefs related to the pharmaceutical industry. The Angiotech Pharmaceuticals Inc. is offering $200 million to $300 million in convertible notes to develop a new operating unit and minimize debt. MedMira Inc. is considering to sell $104,650 against its equity line of...

  • Angiotech Pharmaceuticals files for bankruptcy protection.  // Medical Device Daily;1/31/2011, Vol. 15 Issue 20, p4 

    The article unveils the plan of Angiotech Pharmaceuticals to file for bankruptcy protection under the Companies' Creditors Arrangement Act of Canada.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics